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Background
The utility of the core outcome variable (COV) classifica-
tion procedure as a method of gauging response to treat-
ment in JIA is often jeopardised by missing data. To
investigate how accurately cases are classified as respond-
ers or non-responders with a limited set of data, this study
systematically examined how the exclusion of core varia-
bles influenced classification.
Methods
From a complete dataset of 410 JIA patients (provided by
PRINTO), variables were systematically excluded and
cases reclassified as responders or non-responders accord-
ing to the criteria of improvement at 30%, 50% or 70%.
Comparisons of the sensitivity, specificity were utilised to
calculate overall accuracy of classification for each limited
dataset in comparison to classification via the full dataset.
Results
The systematic removal of one variable resulted in low-
ered accuracy of classification in the ranges of 86.5–
91.8%, 81.7–93.9% and 79.5–88.6% at the 30%, 70%
and 50% criteria levels. Exclusion of the CHAQ had the
least impact, while exclusion of the number of active
joints had the greatest impact on accuracy. As the percent-
age criteria became more stringent the overall accuracy
reduced, however even at the 70% criteria up to 89% accu-
racy was possible if only the CHAQ was omitted. The
omission of both parental global rating and the CHAQ
had a particularly large impact on sensitivity and accuracy.
Conclusion
It is possible that a limited set of variables can lead to a rel-
atively accurate indication of the response to treatment by
JIA patients, but careful consideration of the precise varia-
ble(s) omitted is required.
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